Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 10INDUSTRY 2NIH 1FED 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2NET 1Genitourinary 1Endocrine 1Breast 1

Conditions

Carcinoma, Hepatocellular 2Prostatic Neoplasms 1Neuroendocrine Tumors 1Liver Neoplasms 1Liver Abscess 1Colorectal Neoplasms 1Carcinoma 1Breast Neoplasms 1Adenoma 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × gadolinium ethoxybenzyl DTPA × Clear all
NCT04373564 2026-01-22

ODYSSEY

Guerbet

Phase 4 Recruiting
2,076 enrolled
BreastEndocrineGastrointestinalGenitourinaryNET

Breast Neoplasms, Carcinoma, Hepatocellular, Prostatic Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors

NCT01043523 2016-11-28

Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

Bayer

Completed
52 enrolled 27 charts
Gastrointestinal

Adenoma, Carcinoma, Carcinoma, Hepatocellular, Liver Abscess, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡